$76.10
-0.43-0.56%
al cierre: -
$76.10
0.000.00%
After hour: 4:00 PM EDT
Comments
Loading...
Edwards Lifesciences Actividad de operaciones con información privilegiada
EWNYSE
Actividad de operaciones de insiders
Sigue la actividad de operaciones con información privilegiada más reciente de Edwards Lifesciences. Mantente informado sobre las compras, ventas e impacto en el mercado recientes de las acciones de Edwards Lifesciences.
¿Qué es la actividad interna?
La actividad de uso de información privilegiada involucra a personas con información privilegiada de la empresa, como ejecutivos, directores y empleados, que participan en transacciones con acciones de su propia empresa. Las transacciones de compra y venta de los iniciados proporcionan información valiosa sobre su confianza en el desempeño futuro de la empresa.
¿Qué están haciendo Edwards Lifesciences Corp los iniciados?
Los expertos no han informado de compras ni ventas en los últimos 30 días.
Compras y ventas recientes notables de información privilegiada
- El agosto 25, 2025, Daveen Chopra, la empresa CVP, TMTT sold 2.5K acciones por $81.95 cada una.
- El julio 28, 2025, Daniel Lippis, la empresa CVP, JAPAC sold 4.11K acciones por $79.46 cada una.
Estadísticas de propiedad de Edwards Lifesciences Corp
Acciones en circulación
587.100M
Acciones en manos de personas con información privilegiada
1.887M
Porcentaje de acciones en manos de personas con información privilegiada
0.32%
Acciones en manos de instituciones
344.498M
Porcentaje de acciones en manos de instituciones
58.7%
Aug 25, 2025 | CVP, TMTT | -2.50K | $81.95 | -$204.87K | SELL | -7.46% | 31.00K | Aug 25 | ||
Aug 18, 2025 | GLOBAL PRESIDENT TAVR & SURG | 0.00 | $68.66 | -$168.33K | SELL-OPTIONS | 0.00% | 207.05K | Aug 18 | ||
Jul 28, 2025 | CVP, JAPAC | -4.11K | $79.46 | -$326.90K | SELL | -15.75% | 22.00K | Jul 28 | ||
Jun 16, 2025 | GLOBAL PRESIDENT TAVR & SURG | 0.00 | $67.24 | -$142.92K | SELL-OPTIONS | 0.00% | 207.05K | Jun 16 | ||
Jun 03, 2025 | CEO | -17.07K | $77.22 | -$1.32M | SELL | -58.31% | 12.20K | May 30 - Jun 03 | ||
Jun 02, 2025 | CVP,STRATEGY/CORP DEVELOPMENT | -2.57K | $77.40 | -$198.91K | SELL | -1.37% | 185.51K | Jun 02 | ||
May 22, 2025 | CVP, TMTT | -1.50K | $75.08 | -$112.61K | SELL | -4.29% | 33.50K | May 22 | ||
May 09, 2025 | CVP, JAPAC | 4.22K | $59.85 | -$9.62K | SELL-OPTIONS | 18.87% | 26.62K | May 08 - May 09 | ||
May 09, 2025 | GM & SVP, SURGICAL | 2.78K | $74.99 | -$42.60K | GRANT | 29.08% | 12.35K | May 07 - May 08 | ||
May 09, 2025 | CVP, CHIEF FINANCIAL OFFICER | 11.99K | $59.87 | -$433.01K | SELL-OPTIONS | 4.06% | 307.42K | May 07 - May 09 | ||
May 06, 2025 | CEO | 412.00 | $60.15 | -$191.07K | SELL-OPTIONS | 2.55% | 16.56K | May 03 - May 06 | ||
Apr 14, 2025 | CVP,STRATEGY/CORP DEVELOPMENT | 0.00 | $57.54 | -$233.07K | SELL-OPTIONS | 0.00% | 182.36K | Apr 14 | ||
Apr 08, 2025 | CVP, JAPAC | 0.00 | $57.94 | -$7.60K | SELL-OPTIONS | 0.00% | 22.86K | Apr 08 | ||
Mar 26, 2025 | CVP, CHIEF FINANCIAL OFFICER | 0.00 | $58.07 | -$287.90K | SELL-OPTIONS | 0.00% | 296.70K | Mar 26 | ||
Mar 13, 2025 | CVP,STRATEGY/CORP DEVELOPMENT | 0.00 | $56.62 | -$215.50K | SELL-OPTIONS | 0.00% | 182.09K | Mar 13 | ||
Mar 10, 2025 | CEO | 1.30K | $57.39 | -$90.55K | SELL-OPTIONS | 10.28% | 13.93K | Mar 10 | ||
Mar 10, 2025 | CVP, JAPAC | 0.00 | $57.38 | -$9.68K | SELL-OPTIONS | 0.00% | 22.59K | Mar 10 | ||
Feb 28, 2025 | CVP, CHIEF FINANCIAL OFFICER | 0.00 | $58.03 | -$286.96K | SELL-OPTIONS | 0.00% | 296.70K | Feb 28 | ||
Feb 14, 2025 | DIRECTOR | 0.00 | $60.87 | -$178.50K | SELL-OPTIONS | 0.00% | 75.37K | Feb 14 | ||
Feb 13, 2025 | CVP, CHIEF FINANCIAL OFFICER | 0.00 | $60.52 | -$342.91K | SELL-OPTIONS | 0.00% | 296.88K | Feb 13 | ||
Feb 13, 2025 | CVP,STRATEGY/CORP DEVELOPMENT | 0.00 | $60.51 | -$198.06K | SELL-OPTIONS | 0.00% | 182.09K | Feb 13 | ||
Feb 13, 2025 | CVP, JAPAC | 0.00 | $60.81 | -$15.53K | SELL-OPTIONS | 0.00% | 23.19K | Feb 13 | ||
Feb 13, 2025 | DIRECTOR | 0.00 | $60.59 | -$175.30K | SELL-OPTIONS | 0.00% | 30.04K | Feb 13 | ||
Jan 16, 2025 | CVP, JAPAC | 0.00 | $57.02 | -$11.74K | SELL-OPTIONS | 0.00% | 23.19K | Jan 16 | ||
Jan 16, 2025 | CVP,STRATEGY/CORP DEVELOPMENT | 0.00 | $57.01 | -$117.35K | SELL-OPTIONS | 0.00% | 182.09K | Jan 16 | ||
Dec 16, 2024 | CVP, JAPAC | 0.00 | $59.68 | -$72.00K | SELL-OPTIONS | 0.00% | 23.19K | Dec 16 | ||
Dec 09, 2024 | CVP, CHIEF FINANCIAL OFFICER | 0.00 | $58.48 | -$297.04K | SELL-OPTIONS | 0.00% | 296.88K | Dec 09 | ||
Dec 09, 2024 | CVP,STRATEGY/CORP DEVELOPMENT | 0.00 | $58.51 | -$132.37K | SELL-OPTIONS | 0.00% | 182.09K | Dec 09 | ||
Dec 06, 2024 | CVP, TMTT | -1.75K | $73.27 | -$128.22K | SELL | -5.97% | 27.58K | Dec 06 | ||
Dec 06, 2024 | GM & SVP, SURGICAL | -583.00 | $73.27 | -$42.72K | SELL | -5.79% | 9.49K | Dec 06 | ||
Nov 13, 2024 | CVP,STRATEGY/CORP DEVELOPMENT | 0.00 | $55.42 | -$101.46K | SELL-OPTIONS | 0.00% | 182.09K | Nov 13 | ||
Nov 05, 2024 | GLOBAL PRESIDENT TAVR & SURG | -25.00K | $65.91 | -$1.65M | SELL | -11.18% | 198.67K | Nov 05 | ||
Oct 15, 2024 | CVP,STRATEGY/CORP DEVELOPMENT | 0.00 | $57.39 | -$121.15K | SELL-OPTIONS | 0.00% | 182.09K | Oct 15 | ||
Sep 11, 2024 | CVP,STRATEGY/CORP DEVELOPMENT | 0.00 | $56.02 | -$107.44K | SELL-OPTIONS | 0.00% | 182.09K | Sep 11 | ||
Aug 20, 2024 | CVP, TMTT | -1.25K | $69.95 | -$87.44K | SELL | -4.09% | 29.33K | Aug 20 | ||
Aug 14, 2024 | CVP,STRATEGY/CORP DEVELOPMENT | 0.00 | $55.68 | -$104.04K | SELL-OPTIONS | 0.00% | 182.09K | Aug 14 | ||
Jul 11, 2024 | CVP, JAPAC | 0.00 | $69.73 | -$24.45K | SELL-OPTIONS | 0.00% | 23.19K | Jul 11 | ||
Jul 10, 2024 | CVP,STRATEGY/CORP DEVELOPMENT | 0.00 | $69.29 | -$240.09K | SELL-OPTIONS | 0.00% | 182.09K | Jul 10 | ||
Jun 20, 2024 | CVP, JAPAC | 0.00 | $67.64 | -$23.93K | SELL-OPTIONS | 0.00% | 23.51K | Jun 20 | ||
Jun 20, 2024 | CVP, CHIEF FINANCIAL OFFICER | 0.00 | $66.39 | -$237.58K | SELL-OPTIONS | 0.00% | 296.88K | Jun 20 | ||
Jun 12, 2024 | CVP,STRATEGY/CORP DEVELOPMENT | 0.00 | $66.41 | -$211.31K | SELL-OPTIONS | 0.00% | 182.09K | Jun 12 | ||
May 30, 2024 | CEO | -8.62K | $87.68 | -$755.54K | SELL | -10.76% | 71.49K | May 30 | ||
May 21, 2024 | CVP, CHIEF FINANCIAL OFFICER | 0.00 | $67.87 | -$254.12K | SELL-OPTIONS | 0.00% | 296.88K | May 21 | ||
May 13, 2024 | CVP,STRATEGY/CORP DEVELOPMENT | -814.00 | $66.47 | -$283.24K | SELL | -0.45% | 182.09K | May 10 - May 11 | ||
May 09, 2024 | CVP, JAPAC | 6.97K | $61.07 | -$91.73K | SELL-OPTIONS | 41.23% | 23.89K | May 07 | ||
May 07, 2024 | CEO | 2.60K | $85.48 | -$312.03K | BUY | 389.61% | 3.27K | May 03 - May 06 | ||
May 02, 2024 | DIRECTOR | 0.00 | $60.76 | -$1.41M | SELL-OPTIONS | 0.00% | 4.04M | May 02 | ||
May 01, 2024 | CVP, EMEACLA AND JAPAC | 0.00 | $60.48 | -$683.49K | SELL-OPTIONS | 0.00% | 173.85K | May 01 | ||
Apr 30, 2024 | CVP, CHIEF FINANCIAL OFFICER | 0.00 | $61.28 | -$355.62K | SELL-OPTIONS | 0.00% | 285.39K | Apr 30 | ||
Apr 09, 2024 | CVP, JAPAC | 0.00 | $64.55 | -$47.64K | SELL-OPTIONS | 0.00% | 17.49K | Apr 09 | ||
Apr 08, 2024 | CVP, EMEACLA | 0.00 | $64.54 | -$800.27K | SELL-OPTIONS | 0.00% | 173.85K | Apr 08 | ||
Apr 08, 2024 | CVP,STRATEGY/CORP DEVELOPMENT | 0.00 | $64.54 | -$694.77K | SELL-OPTIONS | 0.00% | 174.92K | Apr 08 | ||
Apr 04, 2024 | DIRECTOR | 0.00 | $64.58 | -$1.63M | SELL-OPTIONS | 0.00% | 4.04M | Apr 04 | ||
Apr 01, 2024 | CVP, CHIEF FINANCIAL OFFICER | 0.00 | $65.82 | -$421.80K | SELL-OPTIONS | 0.00% | 285.39K | Apr 01 | ||
Mar 13, 2024 | CVP,STRATEGY/CORP DEVELOPMENT | 0.00 | $63.88 | -$786.82K | SELL-OPTIONS | 0.00% | 174.65K | Mar 13 | ||
Mar 11, 2024 | CVP, EMEACLA AND JAPAC | 0.00 | $64.21 | -$790.95K | SELL-OPTIONS | 0.00% | 173.58K | Mar 11 | ||
Mar 07, 2024 | CVP, JAPAC | 0.00 | $63.87 | -$93.00K | SELL-OPTIONS | 0.00% | 17.21K | Mar 07 | ||
Mar 04, 2024 | DIRECTOR | 0.00 | $61.71 | -$1.47M | SELL-OPTIONS | 0.00% | 4.04M | Mar 04 | ||
Feb 29, 2024 | CVP, CHIEF FINANCIAL OFFICER | 0.00 | $61.17 | -$354.30K | SELL-OPTIONS | 0.00% | 285.39K | Feb 29 | ||
Feb 26, 2024 | DIRECTOR | 4.00K | $62.24 | -$7.80K | SELL-OPTIONS | 6.32% | 67.22K | Feb 23 | ||
Feb 21, 2024 | CVP, TMTT | -1.20K | $73.00 | -$296.47K | SELL | -5.01% | 22.75K | Feb 21 | ||
Feb 15, 2024 | CVP, CRITICAL CARE | 0.00 | $61.36 | -$2.31M | SELL-OPTIONS | 0.00% | 34.81K | Feb 13 - Feb 15 | ||
Feb 13, 2024 | CVP,STRATEGY/CORP DEVELOPMENT | 0.00 | $61.29 | -$539.91K | SELL-OPTIONS | 0.00% | 174.65K | Feb 13 | ||
Feb 12, 2024 | SVP, CORPORATE CONTROLLER | 0.00 | $61.88 | -$613.55K | SELL-OPTIONS | 0.00% | 33.50K | Feb 12 | ||
Feb 08, 2024 | DIRECTOR | 0.00 | $61.66 | -$349.88K | SELL-OPTIONS | 0.00% | 26.98K | Feb 08 | ||
Feb 05, 2024 | DIRECTOR | 0.00 | $62.12 | -$1.49M | SELL-OPTIONS | 0.00% | 4.04M | Feb 05 | ||
Feb 01, 2024 | CVP, CHIEF FINANCIAL OFFICER | 0.00 | $57.52 | -$301.37K | SELL-OPTIONS | 0.00% | 285.57K | Feb 01 | ||
Jan 12, 2024 | CVP,STRATEGY/CORP DEVELOPMENT | 0.00 | $56.21 | -$389.20K | SELL-OPTIONS | 0.00% | 174.65K | Jan 12 | ||
Jan 05, 2024 | DIRECTOR | 0.00 | $54.87 | -$1.06M | SELL-OPTIONS | 0.00% | 4.04M | Jan 05 | ||
Dec 29, 2023 | CVP, CHIEF FINANCIAL OFFICER | 0.00 | $56.65 | -$577.55K | SELL-OPTIONS | 0.00% | 285.57K | Dec 29 | ||
Dec 15, 2023 | CVP, TMTT | 0.00 | $68.75 | -$132.93K | SELL-OPTIONS | 0.00% | 23.95K | Dec 15 | ||
Dec 13, 2023 | CVP,STRATEGY/CORP DEVELOPMENT | 0.00 | $54.30 | -$280.88K | SELL-OPTIONS | 0.00% | 174.65K | Dec 13 | ||
Dec 13, 2023 | GLOBAL PRESIDENT TAVR & SURG | 0.00 | $58.57 | -$230.16K | SELL-OPTIONS | 0.00% | 214.29K | Dec 13 | ||
Dec 13, 2023 | DIRECTOR | 0.00 | $55.68 | -$1.11M | SELL-OPTIONS | 0.00% | 4.04M | Dec 13 | ||
Dec 06, 2023 | CVP, TMTT | 0.00 | $64.63 | -$37.61K | SELL-OPTIONS | 0.00% | 23.95K | Dec 06 | ||
Nov 13, 2023 | GLOBAL PRESIDENT TAVR & SURG | 0.00 | $55.29 | -$173.36K | SELL-OPTIONS | 0.00% | 214.29K | Nov 13 | ||
Nov 13, 2023 | CVP,STRATEGY/CORP DEVELOPMENT | 0.00 | $51.02 | -$171.28K | SELL-OPTIONS | 0.00% | 174.65K | Nov 13 | ||
Nov 06, 2023 | DIRECTOR | 0.00 | $51.97 | -$893.12K | SELL-OPTIONS | 0.00% | 4.04M | Nov 03 - Nov 06 | ||
Oct 31, 2023 | CVP, CHIEF FINANCIAL OFFICER | 0.00 | $49.70 | -$187.95K | SELL-OPTIONS | 0.00% | 285.57K | Oct 31 | ||
Oct 13, 2023 | GLOBAL PRESIDENT TAVR & SURG | 0.00 | $57.64 | -$214.10K | SELL-OPTIONS | 0.00% | 214.29K | Oct 13 | ||
Oct 13, 2023 | CVP,STRATEGY/CORP DEVELOPMENT | 0.00 | $53.37 | -$166.16K | SELL-OPTIONS | 0.00% | 174.65K | Oct 13 | ||
Oct 10, 2023 | CVP, CRITICAL CARE | 0.00 | $54.72 | -$179.65K | SELL-OPTIONS | 0.00% | 34.81K | Oct 10 | ||
Oct 03, 2023 | CVP, TMTT | 0.00 | $64.63 | -$91.32K | SELL-OPTIONS | 0.00% | 23.95K | Oct 03 | ||
Oct 02, 2023 | DIRECTOR | 0.00 | $52.80 | -$941.84K | SELL-OPTIONS | 0.00% | 3.67M | Oct 02 | ||
Sep 29, 2023 | CVP, CHIEF FINANCIAL OFFICER | 0.00 | $53.15 | -$237.91K | SELL-OPTIONS | 0.00% | 285.57K | Sep 29 | ||
Sep 14, 2023 | CVP,STRATEGY/CORP DEVELOPMENT | 0.00 | $55.23 | -$166.32K | SELL-OPTIONS | 0.00% | 174.65K | Sep 14 | ||
Sep 14, 2023 | GLOBAL PRESIDENT TAVR & SURG | 0.00 | $59.45 | -$245.52K | SELL-OPTIONS | 0.00% | 214.29K | Sep 14 | ||
Sep 08, 2023 | CVP, CRITICAL CARE | 0.00 | $56.38 | -$196.25K | SELL-OPTIONS | 0.00% | 34.81K | Sep 08 | ||
Sep 06, 2023 | CVP, TMTT | 0.00 | $67.66 | -$142.93K | SELL-OPTIONS | 0.00% | 23.95K | Sep 06 | ||
Sep 05, 2023 | DIRECTOR | 0.00 | $56.30 | -$1.15M | SELL-OPTIONS | 0.00% | 3.67M | Sep 05 | ||
Aug 31, 2023 | CVP, CHIEF FINANCIAL OFFICER | 0.00 | $57.27 | -$297.75K | SELL-OPTIONS | 0.00% | 285.57K | Aug 31 | ||
Aug 29, 2023 | CVP, TMTT | -1.50K | $76.69 | -$115.04K | SELL | -5.89% | 23.95K | Aug 29 | ||
Aug 14, 2023 | CVP,STRATEGY/CORP DEVELOPMENT | 0.00 | $58.02 | -$191.47K | SELL-OPTIONS | 0.00% | 174.65K | Aug 14 | ||
Aug 14, 2023 | GLOBAL PRESIDENT TAVR & SURG | 0.00 | $62.29 | -$218.46K | SELL-OPTIONS | 0.00% | 214.29K | Aug 14 | ||
Aug 10, 2023 | DIRECTOR | -3.30K | $78.87 | -$260.51K | SELL | -10.91% | 26.98K | Aug 10 | ||
Aug 09, 2023 | CVP, CRITICAL CARE | 0.00 | $57.69 | -$209.44K | SELL-OPTIONS | 0.00% | 34.81K | Aug 09 | ||
Aug 07, 2023 | DIRECTOR | 0.00 | $58.31 | -$1.27M | SELL-OPTIONS | 0.00% | 3.67M | Aug 07 | ||
Jul 31, 2023 | CVP, CHIEF FINANCIAL OFFICER | 0.00 | $60.55 | -$345.34K | SELL-OPTIONS | 0.00% | 285.57K | Jul 31 | ||
Jul 14, 2023 | CVP,STRATEGY/CORP DEVELOPMENT | 0.00 | $64.84 | -$196.65K | SELL-OPTIONS | 0.00% | 174.65K | Jul 14 | ||
Jul 14, 2023 | GLOBAL PRESIDENT TAVR & SURG | 0.00 | $69.11 | -$412.75K | SELL-OPTIONS | 0.00% | 214.29K | Jul 14 | ||
Jul 10, 2023 | CVP, CRITICAL CARE | -252.00 | $63.63 | -$291.65K | SELL | -0.72% | 34.81K | Jul 07 - Jul 10 | ||
Jul 05, 2023 | DIRECTOR | 0.00 | $63.77 | -$1.59M | SELL-OPTIONS | 0.00% | 3.67M | Jul 05 | ||
Jun 30, 2023 | CVP, CHIEF FINANCIAL OFFICER | 0.00 | $65.01 | -$410.05K | SELL-OPTIONS | 0.00% | 285.57K | Jun 30 | ||
Jun 14, 2023 | CVP,STRATEGY/CORP DEVELOPMENT | 0.00 | $63.26 | -$185.57K | SELL-OPTIONS | 0.00% | 174.65K | Jun 14 | ||
Jun 14, 2023 | GLOBAL PRESIDENT TAVR & SURG | 0.00 | $67.71 | -$388.58K | SELL-OPTIONS | 0.00% | 214.29K | Jun 14 | ||
Jun 13, 2023 | CVP, CRITICAL CARE | 0.00 | $61.28 | -$245.29K | SELL-OPTIONS | 0.00% | 35.06K | Jun 13 | ||
Jun 01, 2023 | DIRECTOR | 0.00 | $60.60 | -$1.40M | SELL-OPTIONS | 0.00% | 3.70M | Jun 01 | ||
May 24, 2023 | GLOBAL PRESIDENT TAVR & SURG | 0.00 | $64.75 | -$250.12K | SELL-OPTIONS | 0.00% | 214.29K | May 24 | ||
May 11, 2023 | CVP,STRATEGY/CORP DEVELOPMENT | 0.00 | $62.98 | -$131.18K | SELL-OPTIONS | 0.00% | 168.23K | May 10 | ||
May 11, 2023 | CVP, CHIEF FINANCIAL OFFICER | 0.00 | $61.87 | -$4.30M | SELL-OPTIONS | 0.00% | 276.12K | May 10 | ||
May 11, 2023 | CHAIRMAN & CEO | 30.28K | $61.84 | -$724.75K | SELL-OPTIONS | 0.76% | 3.99M | May 07 - May 10 | ||
May 09, 2023 | CVP, EMEACLA AND JAPAC | 3.03K | $61.94 | -$384.24K | SELL-OPTIONS | 1.79% | 172.09K | May 07 - May 09 | ||
May 09, 2023 | CVP, CRITICAL CARE | 1.18K | $62.07 | -$4.38M | SELL-OPTIONS | 4.31% | 28.53K | May 07 - May 09 | ||
May 08, 2023 | CVP,STRATEGY/CORP DEVELOPMENT | -5.24K | $88.68 | -$886.93K | SELL | -3.02% | 168.23K | May 05 - May 08 | ||
Apr 28, 2023 | SVP, CORPORATE CONTROLLER | 0.00 | $61.20 | -$638.08K | SELL-OPTIONS | 0.00% | 32.16K | Apr 28 | ||
Apr 17, 2023 | CHAIRMAN & CEO | 9.50K | $59.70 | -$639.53K | SELL-OPTIONS | 0.24% | 3.98M | Apr 14 | ||
Apr 06, 2023 | CVP,STRATEGY/CORP DEVELOPMENT | 0.00 | $59.14 | -$322.10K | SELL-OPTIONS | 0.00% | 180.14K | Apr 06 | ||
Apr 06, 2023 | CVP, EMEACLA AND JAPAC | 0.00 | $59.15 | -$318.06K | SELL-OPTIONS | 0.00% | 169.14K | Apr 06 | ||
Mar 15, 2023 | CVP, TMTT | 0.00 | $61.37 | -$142.76K | SELL-OPTIONS | 0.00% | 18.91K | Mar 15 | ||
Mar 14, 2023 | CHAIRMAN & CEO | 9.50K | $56.40 | -$508.61K | SELL-OPTIONS | 0.24% | 3.97M | Feb 15 - Mar 14 | ||
Mar 08, 2023 | CVP, EMEACLA AND JAPAC | 0.00 | $56.08 | -$277.29K | SELL-OPTIONS | 0.00% | 168.87K | Mar 08 | ||
Mar 08, 2023 | CVP,STRATEGY/CORP DEVELOPMENT | 0.00 | $56.08 | -$280.86K | SELL-OPTIONS | 0.00% | 179.88K | Mar 08 | ||
Feb 16, 2023 | DIRECTOR | 0.00 | $56.25 | -$397.91K | SELL-OPTIONS | 0.00% | 27.48K | Feb 16 | ||
Feb 15, 2023 | CVP, TMTT | 0.00 | $60.64 | -$122.93K | SELL-OPTIONS | 0.00% | 18.91K | Feb 15 | ||
Feb 14, 2023 | CHAIRMAN & CEO | 9.50K | $56.10 | -$496.41K | SELL-OPTIONS | 0.25% | 3.86M | Feb 14 | ||
Feb 06, 2023 | CVP,STRATEGY/CORP DEVELOPMENT | 0.00 | $57.97 | -$306.35K | SELL-OPTIONS | 0.00% | 179.88K | Feb 06 | ||
Jan 17, 2023 | CVP, TMTT | 0.00 | $61.64 | -$130.89K | SELL-OPTIONS | 0.00% | 18.91K | Jan 17 | ||
Jan 13, 2023 | CHAIRMAN & CEO | 9.50K | $56.65 | -$518.22K | SELL-OPTIONS | 0.25% | 3.85M | Jan 13 | ||
Jan 09, 2023 | CVP,STRATEGY/CORP DEVELOPMENT | 0.00 | $56.35 | -$284.49K | SELL-OPTIONS | 0.00% | 179.88K | Jan 09 | ||
Dec 15, 2022 | CVP, SURGICAL STRUCTURAL HEART | 0.00 | $60.04 | -$118.09K | SELL-OPTIONS | 0.00% | 18.91K | Dec 15 | ||
Dec 14, 2022 | CHAIRMAN & CEO | 9.50K | $55.80 | -$484.44K | SELL-OPTIONS | 0.25% | 3.84M | Dec 14 | ||
Dec 13, 2022 | CVP, TAVR | 0.00 | $56.86 | -$291.09K | SELL-OPTIONS | 0.00% | 202.73K | Dec 13 | ||
Dec 12, 2022 | CVP,STRATEGY/CORP DEVELOPMENT | 0.00 | $54.76 | -$263.10K | SELL-OPTIONS | 0.00% | 179.88K | Dec 12 | ||
Nov 15, 2022 | CVP, SURGICAL STRUCTURAL HEART | 0.00 | $59.73 | -$115.61K | SELL-OPTIONS | 0.00% | 18.91K | Nov 15 | ||
Nov 14, 2022 | CHAIRMAN & CEO | 9.50K | $54.67 | -$439.73K | SELL-OPTIONS | 0.25% | 3.84M | Nov 14 | ||
Nov 08, 2022 | CVP,STRATEGY/CORP DEVELOPMENT | 0.00 | $51.83 | -$223.70K | SELL-OPTIONS | 0.00% | 179.88K | Nov 08 | ||
Nov 08, 2022 | CVP, TAVR | 0.00 | $52.62 | -$229.92K | SELL-OPTIONS | 0.00% | 202.73K | Nov 08 | ||
Oct 14, 2022 | CHAIRMAN & CEO | 9.50K | $59.02 | -$612.62K | SELL-OPTIONS | 0.25% | 3.83M | Oct 14 | ||
Oct 14, 2022 | CVP, SURGICAL STRUCTURAL HEART | 0.00 | $65.02 | -$157.97K | SELL-OPTIONS | 0.00% | 18.91K | Oct 14 | ||
Oct 11, 2022 | CVP, TAVR | 0.00 | $59.44 | -$328.57K | SELL-OPTIONS | 0.00% | 202.73K | Oct 11 | ||
Oct 11, 2022 | CVP,STRATEGY/CORP DEVELOPMENT | 0.00 | $60.10 | -$334.93K | SELL-OPTIONS | 0.00% | 179.88K | Oct 10 | ||
Sep 22, 2022 | CHAIRMAN & CEO | 9.50K | $59.68 | -$638.94K | SELL-OPTIONS | 0.25% | 3.82M | Sep 22 | ||
Sep 08, 2022 | CVP,STRATEGY/CORP DEVELOPMENT | 0.00 | $63.07 | -$374.87K | SELL-OPTIONS | 0.00% | 179.88K | Sep 08 | ||
Sep 06, 2022 | CVP, TAVR | 0.00 | $62.88 | -$378.39K | SELL-OPTIONS | 0.00% | 202.73K | Sep 06 | ||
Aug 15, 2022 | CHAIRMAN & CEO | 9.50K | $69.97 | -$1.05M | SELL-OPTIONS | 0.25% | 3.81M | Aug 15 | ||
Aug 09, 2022 | CVP,STRATEGY/CORP DEVELOPMENT | 0.00 | $70.10 | -$469.49K | SELL-OPTIONS | 0.00% | 179.88K | Aug 09 | ||
Aug 09, 2022 | CVP, TAVR | 0.00 | $70.73 | -$492.16K | SELL-OPTIONS | 0.00% | 202.73K | Aug 09 | ||
Aug 05, 2022 | CVP, TMTT | -4.81K | $103.66 | -$498.71K | SELL | -18.46% | 21.25K | Aug 05 | ||
Aug 02, 2022 | CVP, SURGICAL STRUCTURAL HEART | -1.00K | $102.49 | -$102.49K | SELL | -5.02% | 18.91K | Aug 02 | ||
Jul 14, 2022 | CHAIRMAN & CEO | 9.50K | $65.54 | -$871.72K | SELL-OPTIONS | 0.25% | 3.80M | Jul 14 | ||
Jul 08, 2022 | CVP,STRATEGY/CORP DEVELOPMENT | 0.00 | $66.40 | -$419.66K | SELL-OPTIONS | 0.00% | 179.88K | Jul 08 | ||
Jul 08, 2022 | CVP, JAPAN & INTERCONTINENTAL | 0.00 | $66.40 | -$229.33K | SELL-OPTIONS | 0.00% | 99.38K | Jul 08 | ||
Jul 05, 2022 | CVP, TAVR | 0.00 | $66.32 | -$428.34K | SELL-OPTIONS | 0.00% | 202.73K | Jul 05 | ||
Jun 14, 2022 | CHAIRMAN & CEO | 9.50K | $61.08 | -$694.34K | SELL-OPTIONS | 0.25% | 3.79M | Jun 14 | ||
Jun 14, 2022 | CVP, JAPAN & INTERCONTINENTAL | 0.00 | $61.47 | -$193.13K | SELL-OPTIONS | 0.00% | 99.34K | Jun 14 | ||
Jun 14, 2022 | CVP, TMTT | -4.81K | $87.75 | -$421.99K | SELL | -15.61% | 26.01K | Jun 14 | ||
Jun 13, 2022 | CVP,STRATEGY/CORP DEVELOPMENT | 0.00 | $62.61 | -$368.71K | SELL-OPTIONS | 0.00% | 179.88K | Jun 13 | ||
Jun 01, 2022 | CVP, TAVR | 0.00 | $68.64 | -$461.91K | SELL-OPTIONS | 0.00% | 202.69K | Jun 01 | ||
May 31, 2022 | CVP, TMTT | -9.00K | $100.83 | -$907.49K | SELL | -22.60% | 30.82K | May 31 | ||
May 26, 2022 | CVP, SURGICAL STRUCTURAL HEART | -1.00K | $98.31 | -$98.31K | SELL | -4.78% | 19.91K | May 26 | ||
May 24, 2022 | CVP, TMTT | -4.81K | $95.52 | -$459.36K | SELL | -10.78% | 39.82K | May 24 | ||
May 10, 2022 | CHAIRMAN & CEO | 69.33K | $58.29 | -$2.11M | SELL-OPTIONS | 1.87% | 3.78M | May 08 - May 10 | ||
May 10, 2022 | CVP, TAVR | 4.57K | $67.64 | -$1.30M | SELL-OPTIONS | 2.26% | 206.56K | May 07 - May 10 | ||
May 10, 2022 | CVP,STRATEGY/CORP DEVELOPMENT | 4.38K | $67.45 | -$1.25M | SELL-OPTIONS | 2.47% | 181.62K | May 07 - May 09 | ||
May 10, 2022 | CVP, JAPAN & INTERCONTINENTAL | 2.38K | $67.46 | -$693.09K | SELL-OPTIONS | 2.43% | 100.30K | May 07 - May 09 | ||
May 10, 2022 | CVP, EMEA, CANADA, LATIN AMER | 7.87K | $60.06 | -$951.11K | SELL-OPTIONS | 5.07% | 162.90K | May 07 - May 09 | ||
May 05, 2022 | CVP, CRITICAL CARE | 3.28K | $63.32 | -$2.00M | SELL-OPTIONS | 11.90% | 30.85K | May 03 - May 04 | ||
Apr 29, 2022 | CHAIRMAN & CEO | 12.50K | $64.78 | -$2.53M | SELL-OPTIONS | 0.33% | 3.77M | Apr 29 | ||
Apr 28, 2022 | DIRECTOR | 0.00 | $67.04 | -$2.36M | SELL-OPTIONS | 0.00% | 26.78K | Apr 28 | ||
Apr 11, 2022 | CVP, CRITICAL CARE | 0.00 | $71.90 | -$2.01M | SELL-OPTIONS | 0.00% | 27.57K | Apr 11 | ||
Apr 11, 2022 | CVP, EMEA, CANADA, LATIN AMER | 0.00 | $72.53 | -$1.18M | SELL-OPTIONS | 0.00% | 152.33K | Apr 08 | ||
Apr 08, 2022 | CVP,STRATEGY/CORP DEVELOPMENT | 0.00 | $72.55 | -$1.12M | SELL-OPTIONS | 0.00% | 173.96K | Apr 08 | ||
Apr 08, 2022 | CVP, JAPAN & INTERCONTINENTAL | 0.00 | $79.13 | -$322.93K | SELL-OPTIONS | 0.00% | 98.22K | Apr 08 | ||
Apr 05, 2022 | CVP, TAVR | 0.00 | $78.89 | -$610.38K | SELL-OPTIONS | 0.00% | 198.14K | Apr 05 | ||
Mar 22, 2022 | CHAIRMAN & CEO | 12.50K | $67.06 | -$2.68M | SELL-OPTIONS | 0.33% | 3.75M | Mar 22 | ||
Mar 14, 2022 | CVP, CRITICAL CARE | 0.00 | $63.21 | -$1.66M | SELL-OPTIONS | 0.00% | 27.41K | Mar 14 | ||
Mar 11, 2022 | CVP,STRATEGY/CORP DEVELOPMENT | 0.00 | $63.88 | -$930.91K | SELL-OPTIONS | 0.00% | 173.72K | Mar 11 | ||
Mar 11, 2022 | CVP, EMEA, CANADA, LATIN AMER | 0.00 | $63.88 | -$982.35K | SELL-OPTIONS | 0.00% | 152.10K | Mar 11 | ||
Mar 08, 2022 | CVP, JAPAN & INTERCONTINENTAL | 0.00 | $71.40 | -$266.08K | SELL-OPTIONS | 0.00% | 98.03K | Mar 08 | ||
Mar 08, 2022 | CVP, TAVR | 0.00 | $71.69 | -$506.04K | SELL-OPTIONS | 0.00% | 197.93K | Mar 08 | ||
Feb 18, 2022 | CVP, CRITICAL CARE | 0.00 | $64.04 | -$1.69M | SELL-OPTIONS | 0.00% | 27.41K | Feb 18 | ||
Feb 15, 2022 | CHAIRMAN & CEO | 12.50K | $65.92 | -$2.60M | SELL-OPTIONS | 0.34% | 3.74M | Feb 15 | ||
Feb 11, 2022 | CVP,STRATEGY/CORP DEVELOPMENT | -7.00K | $66.62 | -$991.48K | SELL | -4.31% | 155.52K | Aug 10 - Feb 11 | ||
Feb 08, 2022 | DIRECTOR | 0.00 | $66.54 | -$2.85M | SELL-OPTIONS | 0.00% | 60.18K | Feb 08 | ||
Feb 08, 2022 | CVP, TAVR | 0.00 | $73.15 | -$319.30K | SELL-OPTIONS | 0.00% | 197.93K | Feb 08 | ||
Feb 08, 2022 | CVP, JAPAN & INTERCONTINENTAL | 0.00 | $65.98 | -$561.59K | SELL-OPTIONS | 0.00% | 98.03K | Feb 08 | ||
Jan 31, 2022 | CVP,STRATEGY/CORP DEVELOPMENT | 1.00K | $61.45 | -$877.23K | SELL-OPTIONS | 0.55% | 181.22K | Dec 22 - Jan 28 | ||
Jan 14, 2022 | CVP, CRITICAL CARE | 0.00 | $70.64 | -$977.66K | SELL-OPTIONS | 0.00% | 27.41K | Jan 14 | ||
Jan 07, 2022 | CVP, JAPAN & INTERCONTINENTAL | 0.00 | $71.96 | -$637.54K | SELL-OPTIONS | 0.00% | 98.03K | Jan 07 | ||
Jan 07, 2022 | CHAIRMAN & CEO | 12.50K | $72.82 | -$3.05M | SELL-OPTIONS | 0.35% | 3.62M | Jan 06 | ||
Dec 20, 2021 | CHAIRMAN & CEO | 12.50K | $70.44 | -$2.90M | SELL-OPTIONS | 0.35% | 3.61M | Dec 20 | ||
Dec 17, 2021 | CVP, CRITICAL CARE | 0.00 | $71.50 | -$994.80K | SELL-OPTIONS | 0.00% | 27.41K | Dec 17 | ||
Dec 10, 2021 | CVP, TAVR | 0.00 | $78.34 | -$675.68K | SELL-OPTIONS | 0.00% | 197.93K | Dec 10 | ||
Dec 10, 2021 | CVP,STRATEGY/CORP DEVELOPMENT | 0.00 | $71.63 | -$1.10M | SELL-OPTIONS | 0.00% | 180.22K | Dec 10 | ||
Dec 10, 2021 | CVP, JAPAN & INTERCONTINENTAL | 0.00 | $71.63 | -$633.34K | SELL-OPTIONS | 0.00% | 98.03K | Dec 10 | ||
Nov 29, 2021 | CVP, EMEA, CANADA, LATIN AMER | 0.00 | $66.17 | -$8.88K | SELL-OPTIONS | 0.00% | 152.10K | Nov 29 | ||
Nov 24, 2021 | DIRECTOR | 1.50K | $112.23 | $168.34K | BUY | 2.41% | 63.81K | Nov 24 | ||
Nov 19, 2021 | CVP, CRITICAL CARE | 0.00 | $69.78 | -$960.33K | SELL-OPTIONS | 0.00% | 27.41K | Nov 18 | ||
Nov 10, 2021 | CVP, TAVR | 0.00 | $77.49 | -$662.37K | SELL-OPTIONS | 0.00% | 372.63K | Nov 10 | ||
Nov 09, 2021 | CHAIRMAN & CEO | 12.50K | $70.83 | -$2.92M | SELL-OPTIONS | 0.35% | 3.59M | Nov 09 | ||
Nov 08, 2021 | CVP, JAPAN & INTERCONTINENTAL | 0.00 | $70.58 | -$620.01K | SELL-OPTIONS | 0.00% | 98.03K | Nov 08 | ||
Nov 05, 2021 | CVP,STRATEGY/CORP DEVELOPMENT | 0.00 | $69.46 | -$1.05M | SELL-OPTIONS | 0.00% | 180.22K | Nov 05 | ||
Oct 18, 2021 | CVP, CRITICAL CARE | 0.00 | $66.08 | -$863.52K | SELL-OPTIONS | 0.00% | 27.41K | Oct 18 | ||
Oct 12, 2021 | CVP, TAVR | 0.00 | $71.60 | -$570.05K | SELL-OPTIONS | 0.00% | 372.63K | Oct 11 | ||
Oct 08, 2021 | CVP,STRATEGY/CORP DEVELOPMENT | 0.00 | $66.12 | -$980.43K | SELL-OPTIONS | 0.00% | 180.22K | Oct 08 | ||
Oct 08, 2021 | CVP, JAPAN & INTERCONTINENTAL | 0.00 | $66.33 | -$566.10K | SELL-OPTIONS | 0.00% | 98.03K | Oct 08 | ||
Oct 01, 2021 | CHAIRMAN & CEO | 12.50K | $66.74 | -$2.66M | SELL-OPTIONS | 0.35% | 3.58M | Oct 01 | ||
Sep 16, 2021 | CHAIRMAN & CEO | 12.50K | $71.47 | -$2.96M | SELL-OPTIONS | 0.35% | 3.57M | Sep 15 | ||
Sep 10, 2021 | CVP,STRATEGY/CORP DEVELOPMENT | 0.00 | $72.01 | -$1.11M | SELL-OPTIONS | 0.00% | 180.22K | Sep 10 | ||
Sep 10, 2021 | CVP, TAVR | 0.00 | $78.89 | -$684.29K | SELL-OPTIONS | 0.00% | 372.63K | Sep 10 | ||
Sep 08, 2021 | CVP, JAPAN & INTERCONTINENTAL | 0.00 | $71.51 | -$631.77K | SELL-OPTIONS | 0.00% | 98.03K | Sep 08 | ||
Sep 08, 2021 | CVP, CRITICAL CARE | 0.00 | $71.52 | -$969.40K | SELL-OPTIONS | 0.00% | 27.41K | Sep 08 | ||
Aug 10, 2021 | CVP, TAVR | 0.00 | $74.67 | -$618.09K | SELL-OPTIONS | 0.00% | 372.63K | Aug 10 | ||
Aug 09, 2021 | CVP, JAPAN & INTERCONTINENTAL | 0.00 | $68.65 | -$595.50K | SELL-OPTIONS | 0.00% | 98.03K | Aug 09 | ||
Aug 06, 2021 | CVP,STRATEGY/CORP DEVELOPMENT | 0.00 | $68.06 | -$1.02M | SELL-OPTIONS | 0.00% | 180.22K | Aug 06 | ||
Aug 03, 2021 | CHAIRMAN & CEO | 12.50K | $67.95 | -$2.74M | SELL-OPTIONS | 0.35% | 3.56M | Aug 03 | ||
Aug 02, 2021 | CVP, CRITICAL CARE | 0.00 | $67.64 | -$1.38M | SELL-OPTIONS | 0.00% | 27.76K | Aug 02 | ||
Jul 12, 2021 | CVP, TAVR | 0.00 | $71.34 | -$565.98K | SELL-OPTIONS | 0.00% | 372.63K | Jul 12 | ||
Jul 09, 2021 | CVP,STRATEGY/CORP DEVELOPMENT | 0.00 | $64.96 | -$954.66K | SELL-OPTIONS | 0.00% | 180.22K | Jul 09 | ||
Jul 08, 2021 | CVP, JAPAN & INTERCONTINENTAL | 0.00 | $64.24 | -$539.50K | SELL-OPTIONS | 0.00% | 98.03K | Jul 08 | ||
Jul 01, 2021 | CHAIRMAN & CEO | 12.50K | $63.18 | -$2.42M | SELL-OPTIONS | 0.35% | 3.54M | Jul 01 | ||
Jun 15, 2021 | CVP, CRITICAL CARE | 0.00 | $61.73 | -$268.99K | SELL-OPTIONS | 0.00% | 27.70K | Jun 15 | ||
Jun 15, 2021 | CVP, JAPAN & INTERCONTINENTAL | 0.00 | $61.38 | -$503.19K | SELL-OPTIONS | 0.00% | 97.89K | Jun 15 | ||
Jun 14, 2021 | CVP, TAVR | 0.00 | $67.55 | -$506.71K | SELL-OPTIONS | 0.00% | 372.57K | Jun 14 | ||
Jun 14, 2021 | CVP,STRATEGY/CORP DEVELOPMENT | 0.00 | $60.80 | -$862.75K | SELL-OPTIONS | 0.00% | 180.19K | Jun 14 | ||
Jun 14, 2021 | CVP, SURGICAL STRUCTURAL HEART | 0.00 | $72.62 | -$1.31M | SELL-OPTIONS | 0.00% | 15.83K | Jun 14 | ||
Jun 09, 2021 | CHAIRMAN & CEO | 12.50K | $59.50 | -$2.18M | SELL-OPTIONS | 0.36% | 3.53M | Jun 09 | ||
May 28, 2021 | CVP, CRITICAL CARE | -2.06K | $95.29 | -$196.39K | SELL | -6.92% | 27.70K | May 28 | ||
May 25, 2021 | CVP, CRITICAL CARE | -4.67K | $96.09 | -$448.30K | SELL | -13.55% | 29.77K | May 25 | ||
May 25, 2021 | CHAIRMAN & CEO | 0.00 | $58.71 | -$2.44M | SELL-OPTIONS | 0.00% | 3.34M | May 24 | ||
May 11, 2021 | CVP, TAVR | -679.00 | $63.69 | -$508.79K | SELL | -0.18% | 368.17K | May 07 - May 10 | ||
May 07, 2021 | CVP,STRATEGY/CORP DEVELOPMENT | 0.00 | $57.14 | -$781.88K | SELL-OPTIONS | 0.00% | 176.66K | May 07 | ||
May 07, 2021 | CVP, CRITICAL CARE | 0.00 | $57.08 | -$235.82K | SELL-OPTIONS | 0.00% | 30.94K | May 07 | ||
May 07, 2021 | CVP, JAPAN & INTERCONTINENTAL | 0.00 | $56.82 | -$445.20K | SELL-OPTIONS | 0.00% | 95.91K | May 07 | ||
May 05, 2021 | CHAIRMAN & CEO | 30.00K | $53.13 | -$2.36M | SELL-OPTIONS | 0.86% | 3.52M | Apr 27 - May 05 | ||
Apr 23, 2021 | VP, CORPORATE CONTROLLER | -12.00K | $97.66 | -$1.17M | SELL | -28.41% | 30.24K | Apr 23 | ||
Apr 23, 2021 | DIRECTOR | 3.29K | $66.60 | -$297.30K | SELL-OPTIONS | 17.09% | 22.57K | Apr 23 | ||
Apr 22, 2021 | CVP, CRITICAL CARE | 0.00 | $58.34 | -$244.39K | SELL-OPTIONS | 0.00% | 26.97K | Apr 22 | ||
Apr 12, 2021 | CVP, TAVR | 0.00 | $60.52 | -$396.52K | SELL-OPTIONS | 0.00% | 364.28K | Apr 12 | ||
Apr 09, 2021 | CVP,STRATEGY/CORP DEVELOPMENT | 0.00 | $49.13 | -$919.23K | SELL-OPTIONS | 0.00% | 172.67K | Apr 09 | ||
Apr 08, 2021 | CHAIRMAN & CEO | 30.00K | $49.22 | -$4.41M | SELL-OPTIONS | 0.90% | 3.38M | Apr 08 | ||
Apr 08, 2021 | CVP, JAPAN & INTERCONTINENTAL | 0.00 | $53.32 | -$400.81K | SELL-OPTIONS | 0.00% | 93.44K | Apr 08 | ||
Apr 01, 2021 | CVP, EMEA, CANADA, LATIN AMER | 0.00 | $48.82 | -$907.24K | SELL-OPTIONS | 0.00% | 139.54K | Apr 01 | ||
Mar 15, 2021 | CVP, CRITICAL CARE | 0.00 | $51.97 | -$201.22K | SELL-OPTIONS | 0.00% | 26.75K | Mar 15 | ||
Mar 12, 2021 | CVP,STRATEGY/CORP DEVELOPMENT | 0.00 | $48.41 | -$900.56K | SELL-OPTIONS | 0.00% | 172.33K | Mar 12 | ||
Mar 09, 2021 | CHAIRMAN & CEO | 30.00K | $48.32 | -$4.29M | SELL-OPTIONS | 0.90% | 3.35M | Mar 09 | ||
Mar 08, 2021 | CVP, JAPAN & INTERCONTINENTAL | 0.00 | $51.57 | -$378.52K | SELL-OPTIONS | 0.00% | 93.21K | Mar 08 | ||
Mar 01, 2021 | CVP, TAVR | 0.00 | $59.59 | -$382.05K | SELL-OPTIONS | 0.00% | 363.98K | Mar 01 | ||
Mar 01, 2021 | CVP, EMEA, CANADA, LATIN AMER | 0.00 | $49.35 | -$921.04K | SELL-OPTIONS | 0.00% | 139.22K | Mar 01 | ||
Feb 23, 2021 | CHAIRMAN & CEO | 30.00K | $49.08 | -$4.39M | SELL-OPTIONS | 0.91% | 3.32M | Feb 23 | ||
Feb 16, 2021 | CVP, CRITICAL CARE | 0.00 | $55.24 | -$223.38K | SELL-OPTIONS | 0.00% | 26.75K | Feb 16 | ||
Feb 11, 2021 | CVP, JAPAN & INTERCONTINENTAL | -84.00 | $50.40 | -$856.56K | SELL | -0.09% | 93.21K | Feb 11 | ||
Feb 05, 2021 | CVP,STRATEGY/CORP DEVELOPMENT | 0.00 | $49.89 | -$939.18K | SELL-OPTIONS | 0.00% | 172.33K | Feb 05 | ||
Feb 05, 2021 | DIRECTOR | 14.41K | $52.99 | -$229.45K | SELL-OPTIONS | 31.81% | 59.70K | Feb 04 | ||
Feb 01, 2021 | CVP, EMEA, CANADA, LATIN AMER | 0.00 | $48.26 | -$1.45M | SELL-OPTIONS | 0.00% | 139.22K | Feb 01 | ||
Jan 15, 2021 | CHAIRMAN & CEO | 0.00 | $50.74 | -$4.62M | SELL-OPTIONS | 0.00% | 3.29M | Dec 14 - Jan 15 | ||
Jan 15, 2021 | CVP, JAPAN & INTERCONTINENTAL | -81.00 | $50.63 | -$860.82K | SELL | -0.09% | 93.30K | Jan 15 | ||
Jan 15, 2021 | CVP, CRITICAL CARE | 0.00 | $54.78 | -$220.23K | SELL-OPTIONS | 0.00% | 26.75K | Jan 15 | ||
Jan 08, 2021 | CVP,STRATEGY/CORP DEVELOPMENT | 0.00 | $52.21 | -$999.94K | SELL-OPTIONS | 0.00% | 172.33K | Jan 08 | ||
Jan 04, 2021 | CVP, EMEA, CANADA, LATIN AMER | 0.00 | $52.13 | -$1.61M | SELL-OPTIONS | 0.00% | 139.22K | Jan 04 | ||
Dec 15, 2020 | — | 0.00 | $52.98 | -$669.58K | OPTION EXERCISE | 0.00% | 363.98K | Dec 15 | ||
Dec 15, 2020 | — | 60.00K | $49.23 | -$4.41M | GIFT | 1.88% | 3.26M | Dec 14 | ||
Dec 14, 2020 | — | -84.00 | $49.26 | -$828.96K | OPTION EXERCISE | -0.09% | 93.38K | Dec 14 | ||
Dec 11, 2020 | — | 0.00 | $49.31 | -$923.92K | OPTION EXERCISE | 0.00% | 172.33K | Dec 11 | ||
Nov 17, 2020 | — | 30.00K | $49.54 | -$4.46M | GIFT | 0.94% | 3.23M | Nov 17 | ||
Nov 13, 2020 | — | 0.00 | $47.27 | -$870.49K | OPTION EXERCISE | 0.00% | 172.33K | Nov 13 | ||
Nov 12, 2020 | — | -81.00 | $47.61 | -$790.01K | OPTION EXERCISE | -0.09% | 93.46K | Nov 11 | ||
Nov 09, 2020 | — | -573.86 | $80.33 | -$46.10K | SELL | -0.46% | 124.22K | Nov 06 - Nov 09 | ||
Nov 02, 2020 | — | 0.00 | $47.51 | -$551.02K | OPTION EXERCISE | 0.00% | 363.98K | Nov 02 | ||
Oct 29, 2020 | — | 0.00 | $47.77 | -$1.04M | OPTION EXERCISE | 0.00% | 26.75K | Oct 29 | ||
Oct 26, 2020 | — | 0.00 | $50.28 | -$1.89M | OPTION EXERCISE | 0.00% | 256.37K | Oct 26 |
PREGUNTAS FRECUENTES
¿Es legal el uso de información privilegiada?
Las operaciones con información privilegiada son legales siempre que se notifiquen a la Comisión de Bolsa y Valores (SEC). El comercio ilegal de valores se produce cuando la persona con información privilegiada viola un deber fiduciario o no informa de sus operaciones.
¿Cuáles son algunos ejemplos de manipulación del mercado?
Las operaciones con información privilegiada, los esquemas de pump and dump, el front running y las operaciones de lavado son ejemplos de manipulación del mercado. Los inversores que siguen el movimiento de activos con información privilegiada deben pensar atentamente por qué estos operadores con información privilegiada están negociando sus acciones antes de seguir adelante.
Explora operaciones con información privilegiada sobre todos los valores.